Question 1

What is the difference between affinity, efficacy, and potency in drug design?

Accepted Answer

Affinity measures the strength of interaction between a drug and its target receptor. Efficacy represents the maximum achievable therapeutic effect a drug can produce. Potency indicates the drug quantity needed to produce an effect. Understanding these three properties is essential for optimizing drug candidates during the design process.

Question 2

How do structure-activity relationships guide drug development?

Accepted Answer

Structure-activity relationships, or SAR, study how modifications to a drug's chemical structure influence its affinity, efficacy, and potency. By systematically analyzing these relationships, researchers can rationally design drugs with improved therapeutic properties and reduced side effects. SAR analysis was instrumental in developing selective beta-blockers like metoprolol.

Question 3

What role does QSAR play in modern drug design?

Accepted Answer

Quantitative structure-activity relationships, or QSAR, use mathematical models and computational techniques to correlate a drug's chemical structure with its biological activity. This approach enables researchers to predict and optimize the properties of potential drug candidates without synthesizing every compound, accelerating the drug discovery process.

Question 4

Why were selective beta-blockers developed instead of nonselective ones?

Accepted Answer

First-generation nonselective beta-blockers blocked both β1 and β2 adrenergic receptors, causing undesirable side effects including bradycardia, peripheral vasoconstriction, and bronchoconstriction. SAR analysis helped enhance β1 receptor selectivity, resulting in drugs like metoprolol that maintain therapeutic benefits while minimizing adverse effects.

Question 5

How does metoprolol demonstrate the success of structure-activity relationships?

Accepted Answer

Metoprolol is a selective β1 adrenergic receptor blocker developed through SAR analysis to reduce side effects associated with nonselective blockers. By targeting β1 receptors specifically while minimizing β2 receptor interaction, metoprolol provides effective blood pressure control with fewer complications like bronchoconstriction.

Question 6

What is the primary goal of structure-activity relationship studies in drug discovery?

Accepted Answer

SAR studies aim to understand how chemical structure modifications influence a drug's biological activity, allowing researchers to design safer and more effective medications. By establishing these relationships, scientists can create drugs tailored to specific biological targets with optimized pharmacological properties and improved clinical utility.

Question 7

How do SAR and QSAR approaches improve drug safety and efficacy?

Accepted Answer

SAR and QSAR enable rational drug design by systematically correlating chemical structure with biological activity. These approaches allow researchers to predict how structural changes affect drug properties, optimize therapeutic effects, identify potential side effects early, and develop medications that are safer, more effective, and better suited to specific biological targets.

構造活性相関と医薬品設計